Rice Ferment Filtrate Toxicity
Identifiers
Functions
What are the material safety considerations for RICE FERMENT FILTRATE?
The material safety considerations for RICE FERMENT FILTRATE center on irritation hazards, with GHS classifications indicating it causes skin irritation (H315), serious eye irritation (H319), and may cause respiratory irritation (H335), all at a Warning severity level. These classifications are supported by toxicology data showing no drug-induced liver injury concern and a DILI-negative classification, alongside high acute toxicity thresholds in mice (LD50 values of 25,000 mg/kg and 190,000 mg/kg via intraperitoneal and intravenous routes). For formulators, this means the ingredient presents low systemic toxicity risk but requires attention to local irritation potential, particularly in leave-on products or those applied near eyes or respiratory pathways.
How should hazard classifications and toxicology findings for RICE FERMENT FILTRATE be interpreted together?
Hazard classifications and toxicology findings should be interpreted as indicating a local irritation profile rather than systemic toxicity. The GHS Warning-level classifications for skin, eye, and respiratory irritation contrast with toxicology data showing no liver injury concern (DILI-negative, severity class 0) and very high LD50 values in mice (25,000–190,000 mg/kg), suggesting the primary risk is acute irritation at contact sites rather than systemic effects. This interpretation supports formulation decisions prioritizing irritation mitigation—such as concentration optimization and compatibility testing—over systemic safety concerns. The absence of exposure limits and the lack of ingredient-specific toxicology data mean these conclusions rely on general classifications and should be validated with product-specific testing.
Which exposure routes, dose contexts, or effects are material for RICE FERMENT FILTRATE?
Material exposure routes for RICE FERMENT FILTRATE are dermal, ocular, and respiratory, based on the GHS irritation classifications. The skin and eye irritation hazards (H315, H319) are most relevant for topical cosmetic applications, where the ingredient functions as a skin-conditioning agent, while respiratory irritation (H335) becomes material in powder or aerosolized forms during manufacturing. Acute toxicity data indicate low systemic risk even at high doses (LD50 25,000–190,000 mg/kg in mice), but these values do not address chronic or repeated exposure scenarios typical of daily cosmetic use. The lack of exposure limits and absence of route-specific human data mean the practical exposure profile is defined by irritation potential rather than systemic toxicity, guiding safe-use assessments toward contact-site effects.
Which handling and risk-management measures are relevant for RICE FERMENT FILTRATE?
Relevant risk-management measures for RICE FERMENT FILTRATE include handling precautions to minimize skin, eye, and respiratory contact, consistent with its GHS Warning classifications. For manufacturing, this suggests using protective equipment such as gloves and eye protection, and controlling dust or mist generation to address respiratory irritation (H335). In formulation, the skin-conditioning function and absence of regulatory restrictions or maximum concentration limits in cosmetic applications indicate flexibility, but irritation potential warrants conservative starting concentrations and finished-product irritation testing. The high LD50 values and negative liver toxicity findings reduce concern for systemic exposure, so controls should focus on local effects. No specific handling protocols are provided, so standard practices for irritant ingredients apply.
Which safety evidence gaps should be resolved before making decisions about RICE FERMENT FILTRATE?
Key safety evidence gaps for RICE FERMENT FILTRATE include the absence of ingredient-specific toxicology data, exposure limits, and human clinical safety studies. The available GHS classifications are based on aggregated notification data, and the LD50 values may reflect the vehicle rather than the ferment filtrate, limiting their direct applicability. Additionally, no data address chronic exposure, reproductive toxicity, or sensitization potential, which are critical for daily-use cosmetic products. The lack of a CAS number and maximum concentration limits further complicates regulatory benchmarking. Before finalizing safety assessments, formulators should obtain product-specific irritation and sensitization data, establish occupational exposure limits, and clarify whether the filtrate's composition varies by fermentation process, as this could alter hazard profiles.